New Data Points Away from Hydroxychloroquine as COVID-19 Treatment News Update April 22, 2020 Updated April 23, 2020 The most commonly prescribed treatment for lupus, hydroxychloroquine (best known as Plaquenil) is not effective...
LRA Proudly Shares First Results from the COVID-19 Global Rheumatology Alliance Registry News Update April 20,2020 The Lupus Research Alliance is proud to share that the COVID-19 Global Rheumatology Alliance, of which the...
Are Autoimmune Diseases Increasing in the US? News Update April 16, 2020 A recently published study led by Dr. Gregg Dinse provides compelling evidence that proteins found in...
Research Shows Benefit to Starting Belimumab Sooner Rather Than Later News Update April 16, 2020 Treating people with lupus earlier with belimumab (Benlysta) may work better than as a last option...
LRA Salutes RemeGen on FDA Fast-Track Designation for Potential Lupus Treatment News Update April 16, 2020 The Lupus Research Alliance is pleased to share news that promises to speed up testing and...
Letter from LRA to Top U.S. Health Officials News Update April 12, 2020 Today, the Lupus Research Alliance (LRA) Scientific Advisory Board Chair Dr. Gary Koretzky emailed top...
Carta del presidente de LRA Ken Farber sobre la falta de Plaquenil News Update 8 de abril de 2020 Estimado amigo de Lupus Research Alliance: Como sabrá, debido a la posibilidad de que...
Lupus Therapeutics, Affiliate of Lupus Research Alliance, Developing a Study Focused on Lupus Patients and COVID-19 Press Release New York, NY, April 7, 2020 – Lupus Therapeutics, the clinical trial affiliate of the Lupus Research Alliance...
Lupus Therapeutics, filial de Lupus Research Alliance, desarrolla un estudio que se enfoca en los pacientes con lupus y la COVID-19 News Update April 7, 2020 7 de abril de 2020 Nueva York, NY, 7 de abril de 2020 – Lupus Therapeutics, la filial de...
Lupus and COVID-19:What You Need to Know Webcast on Video News Update April 3, 2020 The Lupus Research Alliance (LRA) hosted a live webcast April 2, 2020 on COVID-19 for people...
LRA Urges Congress to Ensure Lupus Patients Maintain Access to Hydroxychloroquine News Update April 3, 2020 The President and CEO of the LRA, Kenneth Farber wrote personally to Speaker Nancy Pelosi and...
Iguratimod as an Alternative Therapy for Resistant Lupus Nephritis News Update April 1, 2020 An investigational treatment, iguratimod showed positive results in an early clinical study of people with lupus...